{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:30:19Z","timestamp":1761708619057,"version":"3.38.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ijrobp.2010.12.003","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T09:29:52Z","timestamp":1296206992000},"page":"e721-e726","source":"Crossref","is-referenced-by-count":34,"title":["Effect of Whole Pelvic Radiotherapy for Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy and Long-Term Androgen Deprivation Therapy"],"prefix":"10.1016","volume":"81","author":[{"given":"Giovanna","family":"Mantini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Carlo","family":"Mattiucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Frascino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Dinapoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Di Ges\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edy","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio G.","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Numa","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.12.003_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0360-3016(81)90028-6","article-title":"The value of extended field radiation therapy in carcinoma of the prostate","volume":"7","author":"McGowan","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0090-4295(92)90430-5","article-title":"Radiation therapy in prostate cancer: Whole pelvis with prostate boost or small field to prostate?","volume":"40","author":"Ploysongsang","year":"1992","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0360-3016(98)00282-X","article-title":"Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer","volume":"42","author":"Seaward","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib4","first-page":"370","article-title":"Identification of a high-risk clinically localized prostate cancer subgroup receiving maximum benefit from whole-pelvic irradiation","volume":"4","author":"Seaward","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0360-3016(02)02818-3","article-title":"Influence of 3D-CRT pelvic irradiation on outcome in prostate cancer treated with external beam radiotherapy","volume":"53","author":"Pan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0167-8140(84)80018-3","article-title":"External beam radiotherapy in cancer of the prostate: The University of Arizona experience","volume":"1","author":"Aristizabal","year":"1984","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0360-3016(85)90304-9","article-title":"Radiotherapy for prostate carcinoma: The JCRT experience (1968\u20131978). II. Factors related to tumor control and complications","volume":"11","author":"Rosen","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib8","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/1097-0142(19871001)60:7<1489::AID-CNCR2820600715>3.0.CO;2-9","article-title":"Stage C adenocarcinoma of the prostate: An analysis of 551 patients treated with external beam radiation","volume":"60","author":"Zagars","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0360-3016(88)90225-8","article-title":"Elective pelvic irradiation in stage A2.B carcinoma of the prostate: Analysis of RTOG 77-06","volume":"15","author":"Asbell","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0360-3016(97)00926-7","article-title":"Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG 77-06, a phase III study for T1bN0M0 (A2) and T2N0M0 (B) prostate carcinoma","volume":"40","author":"Asbell","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib11","first-page":"100","article-title":"The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer","volume":"16","author":"Pannek","year":"1998","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(17)35410-1","article-title":"The use of prostatic specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer","volume":"150","author":"Partin","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.277.18.1445","article-title":"Combination of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer: A multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","article-title":"Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium","volume":"58","author":"Partin","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0360-3016(94)90138-4","article-title":"Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer","volume":"28","author":"Roach","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib16","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma\u2014Long-term results of phase III RTOG 85-31","volume":"61","author":"Pilepich","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1200\/JCO.2005.08.141","article-title":"Androgen suppression plus radiation versus radiation alone for patients with stage D1\/pathologic node-positive adenocarcinoma of the prostate: Updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31","volume":"23","author":"Lawton","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","article-title":"Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate","volume":"50","author":"Pilepich","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0360-3016(00)01516-9","article-title":"Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate","volume":"49","author":"Lawton","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib20","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","article-title":"Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant androgen deprivation cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group protocol 92-02","volume":"21","author":"Hanks","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib22","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1200\/JCO.2003.05.004","article-title":"Phase III trial comparing whole pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413","volume":"21","author":"Roach","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib23","first-page":"66","article-title":"SPIDER: Managing clinical data of cancer patients treated through a multidisciplinary approach by a palm based system","volume":"5","author":"Valentini","year":"2008","journal-title":"JPH"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0360-3016(01)01644-3","article-title":"Dislocation of small bowel volume within box pelvic treatment fields, using new \u201cup down table\u201d device","volume":"51","author":"Capirci","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"year":"1993","series-title":"ICRU report 50: Prescribing, recording and reporting photon beam therapy","key":"10.1016\/j.ijrobp.2010.12.003_bib25"},{"year":"1999","series-title":"ICRU report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50)","key":"10.1016\/j.ijrobp.2010.12.003_bib26"},{"year":"2002","series-title":"AJCC\u2013UICC cancer staging manual","key":"10.1016\/j.ijrobp.2010.12.003_bib27"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0360-3016(00)01492-9","article-title":"Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: Comparison of American Society of Therapeutic Radiology and Oncology consensus or 1 ng\/mL as endpoint","volume":"49","author":"Perez","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","article-title":"Asymptomatically efficient rank invariant procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"B34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib34","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0022-5347(01)64161-2","article-title":"Laparoscopic pelvic lymph node dissection for prostate cancer: Comparison of the extended and modified techniques","volume":"158","author":"Stone","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib35","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0022-5347(05)65177-4","article-title":"Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis","volume":"167","author":"Heidenreich","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2006.03.011","article-title":"The role of whole pelvic radiotherapy in locally advanced prostate cancer","volume":"79","author":"Dirix","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semradonc.2007.09.005","article-title":"Pelvic lymph node irradiation for prostate cancer: Who, why, and when?","volume":"18","author":"Wang","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1200\/JCO.1999.17.4.1155","article-title":"Consensus statements on radiation therapy for prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy","volume":"17","author":"Cox","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib40","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijrobp.2008.12.082","article-title":"Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma","volume":"75","author":"Aizer","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0360-3016(94)90100-7","article-title":"Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate","volume":"28","author":"Perez","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.12.003_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0360-3016(90)90095-2","article-title":"Bowel complications after radiotherapy for carcinoma of the prostate: The volume effect","volume":"18","author":"Mameghan","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610036400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T06:39:23Z","timestamp":1740897563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610036400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0360301610036400"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.003","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}